Vasileia Tsintari
Overview
Explore the profile of Vasileia Tsintari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsintari V, Walter B, Fend F, Overkamp M, Rothermundt C, Lopez C, et al.
BMC Cancer
. 2022 Jul;
22(1):725.
PMID: 35780096
Background: Metastatic soft tissue sarcoma (STS) are a heterogeneous group of malignancies which are not curable with chemotherapy alone. Therefore, understanding the molecular mechanisms of sarcomagenesis and therapy resistance remains...
2.
Rieger I, Tsintari V, Overkamp M, Fend F, Lopez C, Schittenhelm M, et al.
Front Mol Biosci
. 2021 Nov;
8:727203.
PMID: 34805267
Alternative splicing is a common physiologic mechanism to generate numerous distinct gene products from one gene locus, which can result in unique gene products with differing important functional outcomes depending...
3.
Kallergi G, Tsintari V, Sfakianakis S, Bei E, Lagoudaki E, Koutsopoulos A, et al.
Breast Cancer Res
. 2019 Aug;
21(1):86.
PMID: 31370904
Background: Circulating tumor cells (CTCs) are important for metastatic dissemination of cancer. They can provide useful information, regarding biological features and tumor heterogeneity; however, their detection and characterization are difficult...
4.
Schittenhelm M, Walter B, Tsintari V, Federmann B, Bajrami Saipi M, Akmut F, et al.
EBioMedicine
. 2019 Apr;
42:340-351.
PMID: 30952616
Background: Apoptosis-stimulating Protein of TP53-2 (ASPP2) is a tumor suppressor enhancing TP53-mediated apoptosis via binding to the TP53 core domain. TP53 mutations found in cancers disrupt ASPP2 binding, arguing for...